Substance P mRNA expression during zebrafish development: Influence of mu opioid receptor and cocaine

Neuroscience

Volumn 242, Issue , 2013, Pages 53-68

  López Bellido, Roger ^a   Barreto Valer, Katherine ^a   Rodríguez, Raquel Emilia ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Cocaine; Development; Opioid receptors; Substance P; TAC1

Indexed keywords

COCAINE; DELTA OPIATE RECEPTOR; MESSENGER RNA; MU OPIATE RECEPTOR; SUBSTANCE P;

AMPHIBIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIRD; CLUSTER ANALYSIS; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DIENCEPHALON; DRUG EXPOSURE; EMBRYO; EMBRYO DEVELOPMENT; EPIPHYSIS; GASTRULA; GENE; GENE EXPRESSION; GENE SEQUENCE; HEART; HYPOTHALAMUS; MAMMAL; MOLECULAR CLONING; NEUROMERE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SOMITE; SPECIES DIFFERENCE; SPINAL CORD; TACHYKININ 1 GENE; TELENCEPHALON; ZEBRA FISH;

ANIMALS; CENTRAL NERVOUS SYSTEM; COCAINE; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKDOWN TECHNIQUES; HUMANS; MYOCARDIUM; PHYLOGENY; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; RNA, MESSENGER; SOMITES; SUBSTANCE P; ZEBRAFISH;

EID: 84877029963     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.03.022     Document Type: Article

References (77)

1. Adelson D., Lao L., Zhang G., Kim W., Marvizon J.C. Substance P release and neurokinin 1 receptor activation in the rat spinal cord increase with the firing frequency of C-fibers. Neuroscience 2009, 161:538-553.
2. Ang S.F., Moochhala S.M., MacAry P.A., Bhatia M. Hydrogen sulfide and neurogenic inflammation in polymicrobial sepsis: involvement of substance P and ERK-NF-kappaB signaling. PLoS One 2011, 6:e24535.
3. Asadi S., Alysandratos K.D., Angelidou A., Miniati A., Sismanopoulos N., Vasiadi M., Zhang B., Kalogeromitros D., Theoharides T.C. Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol 2012, 132:324-329.
4. Ashley P.J., Sneddon L.U., McCrohan C.R. Nociception in fish: stimulus-response properties of receptors on the head of trout Oncorhynchus mykiss. Brain Res 2007, 1166:47-54.
5. Beaudry H., Dubois D., Gendron L. Activation of spinal mu- and delta-opioid receptors potently inhibits substance P release induced by peripheral noxious stimuli. J Neurosci 2011, 31:13068-13077.
6. Biran J., Palevitch O., Ben-Dor S., Levavi-Sivan B. Neurokinin Bs and neurokinin B receptors in zebrafish-potential role in controlling fish reproduction. Proc Natl Acad Sci USA 2012, 109:10269-10274.
7. Cascieri M.A., Huang R.R., Fong T.M., Cheung A.H., Sadowski S., Ber E., Strader C.D. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors. Mol Pharmacol 1992, 41:1096-1099.
8. Chakraborty C., Hsu C.H., Wen Z.H., Lin C.S., Agoramoorthy G. Zebrafish: a complete animal model for in vivo drug discovery and development. Curr Drug Metab 2009, 10:116-124.
9. Chien C.T., Yu H.J., Lin T.B., Lai M.K., Hsu S.M. Substance P via NK1 receptor facilitates hyperactive bladder afferent signaling via action of ROS. Am J Physiol Renal Physiol 2003, 284:F840-F851.
10. Cipriani G., Serboiu C.S., Gherghiceanu M., Faussone-Pellegrini M.S., Vannucchi M.G. NK receptors, Substance P, Ano1 expression and ultrastructural features of the muscle coat in Cav-1(-/-) mouse ileum. J Cell Mol Med 2011, 15:2411-2420.
11. Commons K.G. Neuronal pathways linking substance P to drug addiction and stress. Brain Res 2010, 1314:175-182.
12. Conlon J.M. Molecular diversity, localization, and biological actions of elasmobranch tachykinins. J Exp Zool 1999, 284:535-540.
13. Dempsey D., Jacob P., Partridge J.C., Jones R.T., Panganiban K., Rowbotham M.C. Cocaine metabolite kinetics in the newborn. J Anal Toxicol 1999, 23:24-28.
14. Dey S., Mactutus C.F., Booze R.M., Snow D.M. Cocaine exposure in vitro induces apoptosis in fetal locus coeruleus neurons by altering the Bax/Bcl-2 ratio and through caspase-3 apoptotic signaling. Neuroscience 2007, 144:509-521.
15. Dunlop R., Laming P. Mechanoreceptive and nociceptive responses in the central nervous system of goldfish (Carassius auratus) and trout (Oncorhynchus mykiss). J Pain 2005, 6:561-568.
16. Frisch P., Bilkei-Gorzo A., Racz I., Zimmer A. Modulation of the CRH system by substance P/NKA in an animal model of depression. Behav Brain Res 2010, 213:103-108.
17. Geppetti P., Bertrand C., Ricciardolo F.L., Nadel J.A. New aspects on the role of kinins in neurogenic inflammation. Can J Physiol Pharmacol 1995, 73:843-847.
18. Gilbert R.F., Emson P.C. Substance P in rat CNS and duodenum during development. Brain Res 1979, 171:166-170.
19. Gonzalez-Nunez V., Rodriguez R.E. The zebrafish: a model to study the endogenous mechanisms of pain. ILAR J 2009, 50:373-386.
20. Guan J.S., Xu Z.Z., Gao H., He S.Q., Ma G.Q., Sun T., Wang L.H., Zhang Z.N., Lena I., Kitchen I., Elde R., Zimmer A., He C., Pei G., Bao L., Zhang X. Interaction with vesicle luminal protachykinin regulates surface expression of delta-opioid receptors and opioid analgesia. Cell 2005, 122:619-631.
21. Harrison S., Geppetti P. Substance p. Int J Biochem Cell Biol 2001, 33:555-576.
22. Hong H.S., Kim do Y., Yoon K.J., Son Y. A new paradigm for stem cell therapy: substance-P as a stem cell-stimulating agent. Arch Pharm Res 2011, 34:2003-2006.
23. Hu S., Cheeran M.C., Sheng W.S., Ni H.T., Lokensgard J.R., Peterson P.K. Cocaine alters proliferation, migration, and differentiation of human fetal brain-derived neural precursor cells. J Pharmacol Exp Ther 2006, 318:1280-1286.
24. Kamata K., Inoue K., Kasuya Y. Changes in contractile responses of the urinary bladder to substance P in streptozotocin-induced diabetic rats. Gen Pharmacol 1993, 24:547-553.
25. Kang H.S., Trzaska K.A., Corcoran K., Chang V.T., Rameshwar P. Neurokinin receptors: relevance to the emerging immune system. Arch Immunol Ther Exp (Warsz) 2004, 52:338-347.
26. Kesrouani A., Fallet C., Vuillard E., Jacqz-Aigrain E., Sibony O., Oury J.F., Blot P., Luton D. Pathologic and laboratory correlation in microcephaly associated with prenatal cocaine exposure. Early Hum Dev 2001, 63:79-81.
27. Kimmel C.B., Ballard W.W., Kimmel S.R., Ullmann B., Schilling T.F. Stages of embryonic development of the zebrafish. Dev Dyn 1995, 203:253-310.
28. Kombian S.B., Ananthalakshmi K.V., Parvathy S.S., Matowe W.C. Dopamine and adenosine mediate substance P-induced depression of evoked IPSCs in the rat nucleus accumbens in vitro. Eur J Neurosci 2003, 18:303-311.
29. Kombian S.B., Ananthalakshmi K.V., Zidichouski J.A., Saleh T.M. Substance P and cocaine employ convergent mechanisms to depress excitatory synaptic transmission in the rat nucleus accumbens in vitro. Eur J Neurosci 2009, 29:1579-1587.
30. Lai J.P., Douglas S.D., Rappaport E., Wu J.M., Ho W.Z. Identification of a delta isoform of preprotachykinin mRNA in human mononuclear phagocytes and lymphocytes. J Neuroimmunol 1998, 91:121-128.
31. Lai J.P., Douglas S.D., Zhao M., Ho W.Z. Quantification of substance P mRNA in human mononuclear phagocytes and lymphocytes using a mimic-based RT-PCR. J Immunol Methods 1999, 230:149-157.
32. Lai J.P., Douglas S.D., Shaheen F., Pleasure D.E., Ho W.Z. Quantification of substance p mRNA in human immune cells by real-time reverse transcriptase PCR assay. Clin Diagn Lab Immunol 2002, 9:138-143.
33. Lee C.T., Chen J., Hayashi T., Tsai S.Y., Sanchez J.F., Errico S.L., Amable R., Su T.P., Lowe R.H., Huestis M.A., Shen J., Becker K.G., Geller H.M., Freed W.J. A mechanism for the inhibition of neural progenitor cell proliferation by cocaine. PLoS Med 2008, 5:e117.
34. Lepsch L.B., Munhoz C.D., Kawamoto E.M., Yshii L.M., Lima L.S., Curi-Boaventura M.F., Salgado T.M., Curi R., Planeta C.S., Scavone C. Cocaine induces cell death and activates the transcription nuclear factor kappa-B in PC12 cells. Mol Brain 2009, 2:3.
35. Lin X.W., Peter R.E. Goldfish gamma-preprotachykinin mRNA encodes the neuropeptides substance P, carassin, and neurokinin A. Peptides 1997, 18:817-824.
36. Lin C.C., Chen W.N., Chen C.J., Lin Y.W., Zimmer A., Chen C.C. An antinociceptive role for substance P in acid-induced chronic muscle pain. Proc Natl Acad Sci USA 2010, 109:E76-E83.
37. Lloyd S.A., Balest Z.R., Corotto F.S., Smeyne R.J. Cocaine selectively increases proliferation in the adult murine hippocampus. Neurosci Lett 2011, 485:112-116.
38. Lohi O., Parikka M., Ramet M. The zebrafish as a model for paediatric diseases. Acta Paediatr 2012, 102:104-110.
39. Loonam T.M., Noailles P.A., Yu J., Zhu J.P., Angulo J.A. Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum. Life Sci 2003, 73:727-739.
40. López-Bellido R., Barreto-Valer K., Sanchez-Simon F.M., Rodriguez R.E. Cocaine modulates the expression of opioid receptors and miR-let-7d in zebrafish embryos. PloS One 2012, 7:e50885.
41. López-Bellido R., Barreto-Valer K., Rodriguez R.E. Expression of tachykinin receptors in zebrafish: influence of cocaine and opioid receptors. J Mol Endocrinol 2013, 50:115-129.
42. Lopez-Patino M.A., Yu L., Cabral H., Zhdanova I.V. Anxiogenic effects of cocaine withdrawal in zebrafish. Physiol Behav 2008, 93:160-171.
43. Maggi C.A. The mammalian tachykinin receptors. Gen Pharmacol 1995, 26:911-944.
44. Minami M., Maekawa K., Yabuuchi K., Satoh M. Double in situ hybridization study on coexistence of mu-, delta- and kappa-opioid receptor mRNAs with preprotachykinin A mRNA in the rat dorsal root ganglia. Brain Res Mol Brain Res 1995, 30:203-210.
45. Myohanen T.T., Venalainen J.I., Garcia-Horsman J.A., Mannisto P.T. Spatial association of prolyl oligopeptidase, inositol 1,4,5-triphosphate type 1 receptor, substance P and its neurokinin-1 receptor in the rat brain: an immunohistochemical colocalization study. Neuroscience 2008, 153:1177-1189.
46. Napier T.C., Mitrovic I., Churchill L., Klitenick M.A., Lu X.Y., Kalivas P.W. Substance P in the ventral pallidum: projection from the ventral striatum, and electrophysiological and behavioral consequences of pallidal substance P. Neuroscience 1995, 69:59-70.
47. Nasevicius A., Ekker S.C. Effective targeted gene 'knockdown' in zebrafish. Nat Genet 2000, 26:216-220.
48. Ogawa S., Ramadasan P.N., Goschorska M., Anantharajah A., Ng K.W., Parhar I.S. Cloning and expression of tachykinins and their association with kisspeptins in the brains of zebrafish. J Comp Neurol 2012, 520:2991-3012.
49. Opolka A., Straub R.H., Pasoldt A., Grifka J., Grässel S. Substance P and norepinephrine modulate murine chondrocyte proliferation and apoptosis. Arthritis Rheum 2012, 64:729-739.
50. Ostlund E., Von Euler U.S. Occurrence of a substance P-like polypeptide in fish intestine and brain. Br J Pharmacol Chemother 1956, 11:323-325.
51. Otsuka M., Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev 1993, 73:229-308.
52. Patacchini R., Maggi C.A. Tachykinin NK1 receptors mediate both vasoconstrictor and vasodilator responses in the rabbit isolated jugular vein. Eur J Pharmacol 1995, 283:233-240.
53. Pennefather J.N., Lecci A., Candenas M.L., Patak E., Pinto F.M., Maggi C.A. Tachykinins and tachykinin receptors: a growing family. Life Sci 2004, 74:1445-1463.
54. Pfeiffer M., Kirscht S., Stumm R., Koch T., Wu D., Laugsch M., Schroder H., Hollt V., Schulz S. Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization. J Biol Chem 2003, 278:51630-51637.
55. Pinal-Seoane N., Martin I.R., Gonzalez-Nunez V., de Velasco E.M., Alvarez F.A., Sarmiento R.G., Rodriguez R.E. Characterization of a new duplicate delta-opioid receptor from zebrafish. J Mol Endocrinol 2006, 37:391-403.
56. Regoli D., Drapeau G., Dion S., D'Orleans-Juste P. Pharmacological receptors for substance P and neurokinins. Life Sci 1987, 40:109-117.
57. Regoli D., Boudon A., Fauchere J.L. Receptors and antagonists for substance P and related peptides. Pharmacol Rev 1994, 46:551-599.
58. Sanchez-Simon F.M., Zhang X.X., Loh H.H., Law P.Y., Rodriguez R.E. Morphine regulates dopaminergic neuron differentiation via miR-133b. Mol Pharmacol 2010, 78:935-942.
59. Santoriello C., Zon L.I. Hooked! Modeling human disease in zebrafish. J Clin Invest 2012, 122:2337-2343.
60. Schedlowski M., Fluge T., Richter S., Tewes U., Schmidt R.E., Wagner T.O. Beta-endorphin, but not substance-P, is increased by acute stress in humans. Psychoneuroendocrinology 1995, 20:103-110.
61. Seybold V.S. The role of peptides in central sensitization. Handb Exp Pharmacol 2009, 451-491.
62. Shaffer A.D., Ball C.L., Robbins M.T., Ness T.J., Randich A. Effects of acute adult and early-in-life bladder inflammation on bladder neuropeptides in adult female rats. BMC Urol 2011, 11:18.
63. Sneddon L.U. Trigeminal somatosensory innervation of the head of a teleost fish with particular reference to nociception. Brain Res 2003, 972:44-52.
64. St John P.A., Stephens S.L. Development of substance P receptors on rat motoneurons in vitro. Dev Biol 1992, 151:154-165.
65. St John P.A., Ludwig C.P., Lai J. Substance P receptor expression and cellular responses to substance P in prenatal rat spinal cord cells. J Recept Signal Transduct Res 1997, 17:569-583.
66. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011, 28:2731-2739.
67. Teodoro F.C., Tronco Junior M.F., Zampronio A.R., Martini A.C., Rae G.A., Chichorro J.G. Peripheral substance P and neurokinin-1 receptors have a role in inflammatory and neuropathic orofacial pain models. Neuropeptides 2012, http://dx.doi.org/10.1016/j.npep.2012.10.005.
68. Van Loy T., Vandersmissen H.P., Poels J., Van Hiel M.B., Verlinden H., Vanden Broeck J. Tachykinin-related peptides and their receptors in invertebrates: a current view. Peptides 2010, 31:520-524.
69. Wan Q., Douglas S.D., Wang X., Kolson D.L., O'Donnell L.A., Ho W.Z. Morphine upregulates functional expression of neurokinin-1 receptor in neurons. J Neurosci Res 2006, 84:1588-1596.
70. West C.H., Michael R.P. Substance P injections into the ventral tegmentum affect unit activity in mesolimbic terminal regions. Brain Res Bull 1991, 26:229-233.
71. Wong B.J., Minson C.T. Neurokinin-1 receptor desensitization attenuates cutaneous active vasodilatation in humans. J Physiol 2006, 577:1043-1051.
72. Yang A.R., Yi H.S., Mamczarz J., June H.L., Hwang B.H., June H.L. Deficits in substance P mRNA levels in the CeA are inversely associated with alcohol-motivated responding. Synapse 2009, 63:972-981.
73. Yik Y.I., Farmer P.J., King S.K., Chow C.W., Hutson J.M., Southwell B.R. Gender differences in reduced substance P (SP) in children with slow-transit constipation. Pediatr Surg Int 2011, 27:699-704.
74. Yu Y.J., Arttamangkul S., Evans C.J., Williams J.T., von Zastrow M. Neurokinin 1 receptors regulate morphine-induced endocytosis and desensitization of mu-opioid receptors in CNS neurons. J Neurosci 2009, 29:222-233.
75. Zhao Z.Q., Lacey G., Hendry I.A., Morton C.R. Substance P release in the cat spinal cord upon afferent C-fibre stimulation is not attenuated by clonidine at analgesic doses. Neurosci Lett 2004, 361:216-219.
76. Zhou W., Li S., Liu Y., Qi X., Chen H., Cheng C.H., Liu X., Zhang Y., Lin H. The evolution of tachykinin/tachykinin receptor (TAC/TACR) in vertebrates and molecular identification of the TAC3/TACR3 system in zebrafish (Danio rerio). Mol Cell Endocrinol 2012, 361:202-212.
77. Zimmer A., Zimmer A.M., Baffi J., Usdin T., Reynolds K., Konig M., Palkovits M., Mezey E. Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proc Natl Acad Sci USA 1998, 95:2630-2635.